Literature DB >> 1721265

A combined HPLC-ELISA evaluation of FK 506 in transplant patients.

M C Friob1, A Hassoun, D Latinne, G Lhoëst, J B Otte, P E Wallemacq.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721265

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  FK506 measurement: comparison of different analytical methods.

Authors:  V Warty; S Zuckerman; R Venkataramanan; J Lever; J Fung; T Starzl
Journal:  Ther Drug Monit       Date:  1993-06       Impact factor: 3.681

Review 2.  Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.

Authors:  P E Wallemacq; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Tacrolimus analysis: a comparison of different methods and matrices.

Authors:  V Warty; S Zuckerman; R Venkataramanan; J Lever; J Chao; T Mckaveney; J Fung; T Starzl
Journal:  Ther Drug Monit       Date:  1995-04       Impact factor: 3.681

Review 4.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

6.  Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA).

Authors:  A K Gonschior; U Christians; F Braun; M Winkler; A Linck; J Baumann; K F Sewing
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

Review 7.  Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors:  Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.